In addition, many studies have expanded the correlation between PDE4 and the pathogenesis of CNS diseases, demonstrating the beneficial effects of PDE4 inhibitors on CNS diseases such as stroke, Alzheimer’s disease, and depression (Richter et al., 2013; Blokland et al., 2019). Here, PDE4A is linked to stroke disorder.